Contemporary multidisciplinary treatment of pregnancy-associated breast cancer

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-7

  Meisel, Jane L ^a   Economy, Katherine E ^a   Calvillo, Katherina Zabicki ^a,d   Schapira, Lydia ^b   Tung, Nadine M ^c   Gelber, Shari ^d   Kereakoglow, Sandra ^d   Partridge, Ann H ^a,d   Mayer, Erica L ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Chemotherapy; Fetal outcomes; Multidisciplinary care; Pregnancy

Indexed keywords

EID: 84881258960     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-297     Document Type: Article

References (39)

1. Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, Beijnen J, Cardoso F, Gentilini O, Lagae L et al (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46 (18):3158-3168
2. Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B, Wouters H et al (2012) Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 13(3):256-264
3. Andersson TM, Johansson AL, Hsieh CC, Cnattingius S, Lambe M (2009) Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol 114(3):568-572
4. Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2 (3):173-177
5. Azim HA Jr, Metzger-Filho O, de Azambuja E, Loibl S, Focant F, Gresko E, Arfi M, Piccart-Gebhart M (2012) Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01). Breast Cancer Res Treat 133(1):387-391
6. Borges VF, Schedin PJ (2011) Pregnancy-associated breast cancer: an entity needing refinement of the definition. Cancer 118(13):3226-3228
7. Braems G, Denys H, De Wever O, Cocquyt V, Van den Broecke R (2011) Use of tamoxifen before and during pregnancy. Oncologist 16(11):1547-1551
8. Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5(5):283-291
9. Cardonick E, Usmani A, Ghaffar S (2010) Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 33 (3):221-228
10. Cardonick E, Bhat A, Gilmandyar D, Somer R (2012a) Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol 23(12):3016-3023
11. Cardonick E, Gilmandyar D, Somer RA (2012b) Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol 120(6):1267-1272
12. Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP et al (2012) Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131(3):1061-1066
13. Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE et al (2003) Severe chronic neutropenia: treatment and follow-up of patients in the severe chronic neutropenia international registry. Am J Hematol 72(2):82-93
14. Dominici LS, Kuerer HM, Babiera G, Hahn KM, Perkins G, Middleton L, Ramirez MM, Yang W, Hortobagyi GN, Theriault RL et al (2010) Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis 31 (1):1-5
15. Elledge RM, Ciocca DR, Langone G, McGuire WL (1993) Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 71(8):2499-2506
16. Gottschalk I, Berg C, Harbeck N, Stressig R, Kozlowski P (2011) Fetal renal insufficiency following trastuzumab treatment for breast cancer in pregnancy: case report und review of the current literature. Breast Care (Basel) 6(6):475-478
17. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi GN, Theriault RL (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107(6):1219-1226
18. Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, Hoffman M, Kominiarek MA, Reddy U, Bailit J, Branch DW et al (2010) Respiratory morbidity in late preterm births. JAMA 304(4):419-425
19. Hill CC, Pickinpaugh J (2008) Physiologic changes in pregnancy. Surg Clin North Am 88(2):391-401, vii
20. Kopans D (1998) The altered breast: pregnancy, lactation, biopsy, mastectomy, radiation, and implants. In: Kopans D (ed) Breast Imaging, 2nd ed. Philadelphia: Lippincott-Raven, pp 445-447
21. Litton JK, Theriault RL (2010) Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist 15(12):1238-1247
22. Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, Fehm T, Van Calsteren K, Linn SC, Schlehe B et al (2012) Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 13(9):887-896
23. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, Mathews TJ, Wilson EC (2011) Births: final data for 2009. Natl Vital Stat Rep 60(1):1-70
24. Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A (2003) Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 98(5):1055-1060
25. Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM, Goldwasser F (2008) Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 19(4):607-613
26. Mir O, Berveiller P, Goffinet F, Treluyer JM, Serreau R, Goldwasser F, Rouzier R (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 21(2):425-426
27. Moran BJ, Yano H, Al Zahir N, Farquharson M (2007) Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol 8(6):536-544
28. Nieto Y, Santisteban M, Aramendia JM, Fernandez-Hidalgo O, Garcia-Manero M, Lopez G (2006) Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer 6(6):533-534
29. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS et al (2010) Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88(12):1008-1016
30. Potluri V, Lewis D, Burton GV (2006) Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer 7(2):167-170
31. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA (2005) Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 23(18):4192-4197
32. Rosenkranz KM, Lucci A (2005) Surgical treatment of pregnancy associated breast cancer. Breast Dis 23:87-93
33. Shapiro-Mendoza CK, Tomashek KM, Kotelchuck M, Barfield W, Nannini A, Weiss J, Declercq E (2008) Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk. Pediatrics 121(2):e223-e232
34. Shaw GM, Wasserman CR, Lammer EJ, O'Malley CD, Murray JC, Basart AM, Tolarova MM (1996) Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 58(3):551-561
35. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM (2001) Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol 184(7):1504-1512, discussion 1512-1503
36. Taylor D, Lazberger J, Ives A, Wylie E, Saunders C (2011) Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us. J Med Imaging Radiat Oncol 55(1):33-42
37. Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683-689
38. Witzel ID, Muller V, Harps E, Janicke F, Dewit M (2008) Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 19(1):191-192
39. Yang WT, Dryden MJ, Gwyn K, Whitman GJ, Theriault R (2006) Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology 239(1):52-60